Exane Derivatives’s Chemed CHE Stock Holding History

Exane Derivatives’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4	Closed	-$2.12K	–	1026
2021 Q4	$2.12K	Sell	4 -138	-97%	-$66.3K	﹤0.01%	665
2021 Q3	$66K	Hold	142	–	–	0.02%	594
2021 Q2	$67.8K	Sell	142 -24	-14%	-$11.5K	0.02%	594
2021 Q1	$76.3K	Sell	166 -8	-5%	-$3.92K	0.02%	460
2020 Q4	$92.7K	Buy	174 +10	+6%	+$4.91K	0.03%	406
2020 Q3	$78.8K	Hold	164	–	–	0.02%	338
2020 Q2	$74K	Hold	164	–	–	0.02%	325
2020 Q1	$71K	Sell	164 -26	-14%	-$11.6K	0.02%	324
2019 Q4	$88.9K	Buy	+190	New	+$79.9K	0.02%	329

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Exane Derivatives's CHE Position: Q1 2022 in Review

Exane Derivatives sold out of Chemed (CHE) in Q1 2022, closing a stake of 4 shares — an estimated $2.12K sold.

Exane Derivatives first reported a position in CHE in Q4 2019 and held it in 9 quarters. The position peaked at $92.7K in Q4 2020. 425 funds tracked by Wall St. Rank hold CHE as of Q1 2022.

Exane Derivatives reported no remaining Chemed position as of Q1 2022 after selling out during the quarter.
Exane Derivatives sold 4 Chemed shares in Q1 2022, an estimated $2.12K.
Exane Derivatives first reported a position in Chemed in Q4 2019 and held it in 9 quarters.
Exane Derivatives's Chemed position peaked at $92.7K in Q4 2020.
425 funds tracked by Wall St. Rank held Chemed as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.